Congenital Adrenal Hyperplasia Clinical Trials

Image of Crinetics Study Site in Morehead City, United States.

Atumelnant for Congenital Adrenal Hyperplasia

Any Age
All Sexes
Morehead City, NC
"This trial aims to assess how safe and effective atumelnant (CRN04894) is over a long period of time."
Phase 2
Recruiting
Has No Placebo
Crinetics Study SiteCrinetics Pharmaceuticals Inc.
Image of Crinetics Study Site in Morehead City, United States.

CRN04894 for Congenital Adrenal Hyperplasia

16 - 75
All Sexes
Morehead City, NC
This trial is testing a new drug called CRN04894 in people with a genetic condition called classic congenital adrenal hyperplasia (CAH). The condition affects hormone production, and current treatments may not work well. The study will see if CRN04894 can safely and effectively help manage hormone levels by targeting the underlying cause of CAH.
Phase 2
Recruiting
Has No Placebo
Crinetics Study Site (+7 Sites)Crinetics Pharmaceuticals Inc.
Image of National Institutes of Health Clinical Center in Bethesda, United States.

Virtual Education Program for Congenital Adrenal Hyperplasia

16 - 22
All Sexes
Bethesda, MD
This trial tests if online lessons can help young people with CAH learn to manage their health as they transition to adult care. It aims to improve their knowledge, medication adherence, and appointment scheduling.
Recruiting
Has No Placebo
National Institutes of Health Clinical CenterRuth W Parker, C.R.N.P.
View More